Inventor
SULLIVAN STEVEN D E
US17 patents
Patents
17 patentsUS10196393B2Feb 5, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC24 citations98
US10550118B2Feb 4, 2020
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC13 citations94
US10526330B2Jan 7, 2020
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10519153B2Dec 31, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC16 citations94
US10392386B2Aug 27, 2019
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC19 citations94
US10208040B2Feb 19, 2019
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC24 citations94
US10100049B2Oct 16, 2018
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US11254669B2Feb 22, 2022
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10954237B2Mar 23, 2021
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC2 citations84
US11453668B2Sep 27, 2022
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11299492B2Apr 12, 2022
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US10952996B2Mar 23, 2021
ALK5 inhibitors
THERAVANCE BIOPHARMA R&D IP LLC2 citations71
US11878977B2Jan 23, 2024
JAK inhibitors containing a 4-membered heterocyclic amide
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11718616B2Aug 8, 2023
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11667637B2Jun 6, 2023
Fused imidazo-piperidine JAK inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations62
US11730720B2Aug 22, 2023
ALK5 inhibitors
THERAVANCE BIOPHARMA R&D IP LLC0 citations60
US11590116B2Feb 28, 2023
Substituted pyridines and methods of use
THERAVANCE BIOPHARMA R&D IP LLC1 citations60